How can we help?

ELT Listing Double Benefits - 20,000,000 ELT in Prizes!

Dear BitMart Users,

 

EliteSwap(ELT) will list on BitMart at 02:00 AM on January 18, 2021 EST! To celebrate the listing of ELT, we are giving away 20,000,000 ELT in our Registration Bonus and Trade To Win event!

 

EN1.png

Promotion Period: 1/18/2021 02:00 AM – 1/23/2021 02:00 AM EST

 

I. Registration Bonus - 5,000,000 ELT Giveaway!

The first 500 new users who register on BitMart via the below link and pass KYC will be eligible to receive 10,000 ELT each.

>>> Register now: https://www.bitmart.com/register/en?r=EliteSwap

 

II. Trade To Win - 15,000,000 ELT Giveaway!

The first 500 users who buy ELT greater than or equal to 300 USDT will be eligible to receive 30,000 ELT each.

 

Note:

  1. The Registration Bonus is only for the first 500 new users using specified referral code to register and who pass KYC.
  2. The Buy & Win reward is only for the first 500 users who buy the required amount of ELT.
  3. Users who use multiple accounts to join will not be qualified for any rewards.
  4. All trades that we deem to be “wash trades” will not count towards for this competition. BitMart reserves the right to freeze any suspected accounts.
  5. Rewards will be distributed within 10 business days (not including CN & US national holidays, and weekends) after the promotion concludes.
  6. Participation is subject to BitMart User Agreement and the terms and conditions applicable to this event. Any questions relating to the offer will be resolved in BitMart’s sole discretion and its decisions related to the offer will be final and binding.

 

ATTENTION: Cryptocurrency investment is subject to high market risk. Please make your investments cautiously. BitMart will make its best effort to list only high-quality coins, but will not be responsible for your investment losses.

 

Thanks for your support!

 

BitMart Team

January 15, 2021

 

Was this article helpful?

39 out of 41 found this helpful

Have more questions? Submit a request

Comments

0 comments

Article is closed for comments.